These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18223510)

  • 21. Resistance exercise training: its role in the prevention of cardiovascular disease.
    Braith RW; Stewart KJ
    Circulation; 2006 Jun; 113(22):2642-50. PubMed ID: 16754812
    [No Abstract]   [Full Text] [Related]  

  • 22. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype.
    Rizzo M; Berneis K; Hersberger M; Pepe I; Di Fede G; Rini GB; Spinas GA; Carmina E
    Hum Reprod; 2009 Sep; 24(9):2286-92. PubMed ID: 19454589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disorders of coagulation and hemostasis in abdominal obesity: emerging role of fatty liver.
    Targher G; Zoppini G; Moghetti P; Day CP
    Semin Thromb Hemost; 2010 Feb; 36(1):41-8. PubMed ID: 20391295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smoking inhibits visceral fat accumulation in Turkish women: relation of visceral fat and body fat mass to atherogenic dyslipidemia, inflammatory markers, insulin resistance, and blood pressure.
    Onat A; Ayhan E; Hergenç G; Can G; Barlan MM
    Metabolism; 2009 Jul; 58(7):963-70. PubMed ID: 19411085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes.
    Zoppini G; Targher G; Trombetta M; Lippi G; Muggeo M
    Obesity (Silver Spring); 2009 Feb; 17(2):370-4. PubMed ID: 19057528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic implications of dietary trans-fatty acids.
    Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
    Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local adipose tissue depots as cardiovascular risk factors.
    Thalmann S; Meier CA
    Cardiovasc Res; 2007 Sep; 75(4):690-701. PubMed ID: 17412312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipodystrophy: lessons in lipid and energy metabolism.
    Simha V; Garg A
    Curr Opin Lipidol; 2006 Apr; 17(2):162-9. PubMed ID: 16531753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity and dyslipidemia.
    Franssen R; Monajemi H; Stroes ES; Kastelein JJ
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):623-33, viii. PubMed ID: 18775355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fat depots, free fatty acids, and dyslipidemia.
    Ebbert JO; Jensen MD
    Nutrients; 2013 Feb; 5(2):498-508. PubMed ID: 23434905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects.
    Viljanen AP; Lautamäki R; Järvisalo M; Parkkola R; Huupponen R; Lehtimäki T; Rönnemaa T; Raitakari OT; Iozzo P; Nuutila P
    Ann Med; 2009; 41(2):152-60. PubMed ID: 18855190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between protein bound sialic acid and high sensitivity C-reactive protein in prehypertension: a possible indication of underlying cardiovascular risk.
    Sathiyapriya V; Selvaraj N; Nandeesha H; Bobby Z; Aparna A; Pavithran P
    Clin Exp Hypertens; 2008 Jul; 30(5):367-74. PubMed ID: 18633759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice.
    Karagiannides I; Abdou R; Tzortzopoulou A; Voshol PJ; Kypreos KE
    FEBS J; 2008 Oct; 275(19):4796-809. PubMed ID: 18754772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The predictive role of atherogenic dyslipidemia in subjects with non-coronary atherosclerosis.
    Berneis K; Rizzo M; Spinas GA; Di Lorenzo G; Di Fede G; Pepe I; Pernice V; Rini GB
    Clin Chim Acta; 2009 Aug; 406(1-2):36-40. PubMed ID: 19433079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenic role of abnormal fatty acids and adipokines in the portal flow. Relevance for metabolic syndrome, hepatic steatosis and steatohepatitis.
    Brudaşcă I; Cucuianu M
    Rom J Intern Med; 2007; 45(2):149-57. PubMed ID: 18333368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dyslipidemia].
    Kihara S
    Nihon Rinsho; 2013 Feb; 71(2):275-9. PubMed ID: 23631206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroendocrine mechanisms in insulin resistance.
    Sjöstrand M; Eriksson JW
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):104-11. PubMed ID: 18599191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.
    Fruchart JC; Sacks F; Hermans MP; Assmann G; Brown WV; Ceska R; Chapman MJ; Dodson PM; Fioretto P; Ginsberg HN; Kadowaki T; Lablanche JM; Marx N; Plutzky J; Reiner Z; Rosenson RS; Staels B; Stock JK; Sy R; Wanner C; Zambon A; Zimmet P
    Am J Cardiol; 2008 Nov; 102(10 Suppl):1K-34K. PubMed ID: 19068318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning, and metabolic syndrome.
    Volek JS; Fernandez ML; Feinman RD; Phinney SD
    Prog Lipid Res; 2008 Sep; 47(5):307-18. PubMed ID: 18396172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.